
Cardionomic
Innovative therapies for acute decompensated heart failure, enhancing patient outcomes and reducing readmissions.
Employees
Enterprise value
$63—95m
Authorizing premium user...
Innovative therapies for acute decompensated heart failure, enhancing patient outcomes and reducing readmissions.